Awareness of HIV-positive status and linkage to treatment prior to pregnancy in the "test and treat" era: A national antenatal sentinel survey, 2017, South Africa.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 02 10 2019
accepted: 15 02 2020
entrez: 14 3 2020
pubmed: 14 3 2020
medline: 19 6 2020
Statut: epublish

Résumé

Knowledge of HIV status in South Africa (SA) is reported to be 90% among people living with HIV. National level estimates could mask population-specific levels, which are critical to monitor program coverage and potential impact. Using data from the 2017 national antenatal sentinel survey, we assessed knowledge of HIV-positive status, initiation of antiretroviral therapy (ART), and socio-demographic characteristics associated with knowledge of HIV-positive status prior to the current pregnancy among women attending antenatal care. Between 1 October and 15 November 2017, a nationally representative sample of 32,716 pregnant women were enrolled from 1,595 public health facilities selected from all districts of SA. Data on age, gravidity, knowledge of HIV-positive status and ART initiation prior to pregnancy were extracted from medical records. A blood sample was collected from each woman regardless of prior knowledge of HIV status or ART history, and tested for HIV in the laboratory. All HIV-positive pregnant women enrolled in the survey were eligible for inclusion in the analysis. Multivariable survey logistic regression was used to examine factors associated with knowledge of HIV-positive status prior to the current pregnancy. Of 10,065 eligible HIV-positive women, 60.8% (95% confidence interval (CI):59.9%-61.7%) knew their HIV status prior to the current pregnancy, of whom 91.1% (95% CI: 90.4%-91.7%) initiated ART prior to the current pregnancy. Knowledge of HIV-positive status was lower among adolescent girls and young women (15-24 years) (38.9%) and primigravid women (40.5%) compared with older women (35-49 years) (75.5%) and multigravid women (64.7%). In a multivariable analysis, significant effect modification was found between gravidity and age (P value = 0.047). Being in the age group 15-24 years compared to the age group 35-49 years decreased the odds of knowing HIV-positive status by 80% (adjusted odds ratio (AOR): 0.2, 95% CI:0.1-0.4) among primigravid women and by 60%(AOR: 0.4, 95% CI:0.3-0.4) among multigravid women. Knowledge of HIV-positive status prior to the current pregnancy fell short of the target of 90% among pregnant women living with HIV. This was especially low among adolescent girls and young women, highlighting the gap in youth friendly reproductive health and HIV testing services.

Identifiants

pubmed: 32168356
doi: 10.1371/journal.pone.0229874
pii: PONE-D-19-27623
pmc: PMC7069609
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0229874

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : PEPFAR
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Infect Dis. 2005 May 1;191(9):1403-9
pubmed: 15809897
Clin Infect Dis. 2015 Dec 1;61(11):1715-25
pubmed: 26197844
PLoS Med. 2017 Jul 25;14(7):e1002361
pubmed: 28742800
J Int AIDS Soc. 2017 Jul 18;20(1):21691
pubmed: 28782333
AIDS. 2011 Sep 24;25(15):1887-95
pubmed: 21785321
BMJ Open. 2016 Oct 17;6(10):e012088
pubmed: 27798004
AIDS Behav. 2011 Nov;15(8):1654-63
pubmed: 21468659
BMC Public Health. 2014 Aug 14;14:843
pubmed: 25124267
Clin Infect Dis. 2008 Aug 15;47(4):577-84
pubmed: 18624629
PLoS One. 2017 Oct 12;12(10):e0186316
pubmed: 29023510
J Glob Health. 2016 Dec;6(2):020405
pubmed: 27698999
AIDS. 2014 Apr 24;28(7):1049-57
pubmed: 24566097
South Afr J HIV Med. 2018 Oct 18;19(1):915
pubmed: 30473876
PLoS Med. 2015 Sep 08;12(9):e1001873
pubmed: 26348035

Auteurs

Selamawit Woldesenbet (S)

Center for HIV and STI, National Institute for Communicable Diseases, Johannesburg, South Africa.
School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Tendesayi Kufa (T)

Center for HIV and STI, National Institute for Communicable Diseases, Johannesburg, South Africa.
School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Mireille Cheyip (M)

Strategic Information Unit, Center for Disease Control and Prevention, Pretoria, South Africa.

Kassahun Ayalew (K)

Strategic Information Unit, Center for Disease Control and Prevention, Pretoria, South Africa.

Carl Lombard (C)

Biostatistics Unit, South African Medical Research Council, Cape Town, South Africa.

Samuel Manda (S)

Biostatistics Unit, South African Medical Research Council, Pretoria, South Africa.

Patrick Nadol (P)

Strategic Information Unit, Center for Disease Control and Prevention, Pretoria, South Africa.

Peter Barron (P)

School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Brian Chirombo (B)

HIV and Hepatitis Program, World Health Organization, Pretoria, South Africa.

Ehi Igumbor (E)

Strategic Information Unit, Center for Disease Control and Prevention, Pretoria, South Africa.
School of Public Health, University of the Western Cape, Bellville, Cape Town, South Africa.

Yogan Pillay (Y)

HIV & AIDS, TB and Maternal, Child and Women's Health (MCWH), National Department of Health, Pretoria, South Africa.

Adrian Puren (A)

Center for HIV and STI, National Institute for Communicable Diseases, Johannesburg, South Africa.
Virology Department, University of the Witwatersrand, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH